Abstract:BACKGROUND: Vascular endothelial growth factor (VEGF) can specifically promote the division and proliferation of endothelial cells and the revascularization, finally induce angiopoiesis. Recently, VEGF-based gene therapy has been gradually used in clinical trials, but some limits on usually used vectors deserve further studies, including the low transfection efficiency of plasmid vector, the immunogenicity of adnovirus vector to host cells and the potential risk of infection. OBJECTIVE: To construct the non-pathogenic recombinant adeno-associated vires (AAV) co-expressing human vascular endethelial growth factor 165 (hVEGF165) and green fluorescent protein (GFP) label and measure the virus titer and assess its biological activity.DESIGN, TIME AND SETTING: The open experiment was performed at the Vitrus Laboratory of Shanxi Provincial Center for Disease Control and Prevention from March to September 2007.MATERIALS: AAV-293 virus packaging cell line, AAV HT-1080 cells were purchased from Swatagene, USA. E.coli DH5α was a stocked strain from Shanxi Provincial Center for Disease Control and Prevention. AAV Helper Free System (pAAV-IRES-GFP vector containing GFP label) was purchased from Stratagene, USA. Plasmid pUC18-hVEGF165 was constructed previously by Dr.Shi from Department of Orthopaedics of Second Affiliated Hospital of Xi'an Jiaotong University.METHODS: The hVEGF165 gone from plasmid pUC18-hVEGF165 was amplified and inserted into plasmid pAAV-IRES-hrGFP. Then recombinant plasmid pAAV-hVEGF165-IRES-hrGFP, pAAV-RC and pAAV-Helper were co-transfected into AAV-293 cells to complete rAAV-hVEGF165-IRES-hrGFP packaging through homologous recombination. The efficiency of A.AV packaging was monitored under a fluorescent microscope, and the recombinant viral particles were harvested from infected AAV-293 cells and further concentrated and purified. The recombinant virus infected the AAV-HT1080 cells, the virus titer was measured by fluorescence counting, and the recombinant AAV-hVEGF165-IRES-hrGFP was verified by the amplification of the exogenous gene of hVEGF165 from virus genome.MAIN OUTCOME MEASURES: Virus packaging efficiency was monitored under the fluorescence microscope. Virus filer was measured by fluorescent counting. The packaging of recombinant virus was determined by the amplification of the exogenous hVEGF165 gene.RESULTS: The amplified products were verified as hVEGF165 gene by DNA sequencing, and the recombinant pAAV-hVEGF165-IRES-hrGFP was confirmed by double digestion. The system provided a high packaging ratio of over 95% and the purified recombinant virus had a high titer of 5.5×1011 vp/mL. The recombinant virus was confirmed by exogenous human VEGF165 gene from virus genome.CONCLUSION: The non-pathogenic rAAV-hVEGF165-GFP simultaneously carrying hVEGF165 and GFP 1abel is successfully constructed, with a high titer and satisfying biological activity.

Cloning of LIGHT gene and construction of its recombinant adenovirus vector

Induction of potent anti-tumor immunity by direct injection of Ad-LIGHT at the site of tumor inoculation.

Cloning and Construction of Adenovirus Expressing Human Angiopoietin-1 or Vascular Endothelial Growth Factor

[Construction and Identification of Recombinant Adenoviral Vector Encoding B7-H4 Gene].

[Cloning of Mouse Adam10 Gene Promoter and Construction and Identification of Dual Luciferase Reporter System].

Gene cloning and identification of shCD40L- IRES2-CTLA4Ig recombination adenovirus vector and exprssion in vitro

The Construction of Recombinant Adenoviral Vector Containing Gene of EWS-FLI1 and Its Expression in PBMC

Construction and Identification of Recombinant Adenovirus Vector Expressing LacZ Gene

Gene cloning of secreted VEGF receptor flt-1 (I similar to IV extracellular domain) and the corresponding recombinant adenovirus construction and expression

Clone of human KLF4 gene and construction of recombinant KLF4 lentiviral vector

Cloning of SARS-CoV-S Gene and Construction of Its Short Interfering RNAs Expression Vector

[Construction of Lentiviral Vector Carrying Human OCT4A Gene and Establishment of Leukemic Cell Line K562 Stably Expressing OCT4A].

Construction of Recombinant Adenovirus with Egr-1 Promoter and Smad7 Cdna and Study of the Egr-1 Promoter's Biological Activity

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

Construction and identification of human chimeric recombinant adenovirus with EEF1A2 gene

Construction and Expression of Recombinant Adenovirus Containing Human Thymic Stromal Lymphopoietin Gene

[Construction and Identification of Recombinant Adenovirus Vector Expressing IkappaBalpha-IRES2-shCD40L].

Construction of Recombinant Adenovirus Coding for Vascular Endothelial Growth Factor Gene

Construction of Adenovirus Vector of Secretory Ciliary Neurotrophic Factor and Increasing of Its Secretion by Replicative Adenovirus

Construction and Identification of Recombinant Adeno- Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor and Green Fluorescent Protein

Rapid Construction of an Infectious Clone of Fowl Adenovirus Serotype 4 Isolate